Scilex Holding (SCLX) Notes Payables (2020 - 2025)

Scilex Holding (SCLX) posted quarterly Notes Payables of $800000.0 for Q3 2025, down 97.89% quarter-over-quarter from $37.9 million in Q4 2021.

Scilex Holding (SCLX) Notes Payables (2020 - 2025) Analysis & Trends

Scilex Holding's Notes Payables history runs 3 years deep, the most recent figure standing at $800000.0 for Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $800000.0 (changed N/A YoY), while the FY2021 annual figure was $37.9 million, up 30260.0% from the prior year.
Notes Payables for Q3 2025 stood at $800000.0, down from $37.9 million in the prior quarter.
The five-year high for Notes Payables was $37.9 million in Q4 2021, with the low at $800000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Johnson & Johnson	645.40 Bn	624.64 Bn	17.26 Bn
2	AbbVie	462.79 Bn	456.22 Bn	12.70 Bn
3	Merck	369.55 Bn	362.41 Bn	12.21 Bn
4	Novartis Ag	298.79 Bn	291.10 Bn	11.24 Bn
5	Astrazeneca	255.57 Bn	250.67 Bn	12.86 Bn
6	Amgen	233.87 Bn	219.89 Bn	7.24 Bn
7	Gilead Sciences	179.24 Bn	176.06 Bn	6.22 Bn
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn
9	Gsk	104.53 Bn	100.36 Bn	8.24 Bn
10	Scilex Holding	39.63 Mn	-73.16 Mn	3.97 Mn

Download Data